Natera (NTRA) | Stock Overview & Key Data
Natera Performance Comparison
Stock Range
Today's Range
Low: $169.90
High: $173.50
on June 20, 2025
52 Week Range
Low: $92.14
High: $183.00
on August 5, 2024
on January 13, 2025
All-Time High: $183.00 on January 13, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$20.9B
EPS
-1.91
P/E Ratio (TTM)
N/A
Forward P/E
-125.58
P/B Ratio
16.68
PEG Ratio
-125.58
Div. Yield
N/A
ROE
-24.32%
Beta
1.756
Debt to Equity
14.69
Financial Highlights
Profitability
Gross Margin
63.12%
Operating Margin
-20.19%
Profit Margin
-12.89%
Returns and Earnings
Return on Assets (TTM)
-11.21%
Return on Equity (TTM)
-24.32%
EBITDA
$-262.7M
Net Income (TTM)
$-253.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$14.81
Quarterly Revenue Growth (YoY)
32.20%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Natera NTRA | 20.85B Large-cap | 7.29% | 8.79% | 9.12% | -3.75% | 1.51% | 31.49% | 223.65% | 147.45% |
| Thermo Fisher TMO | 184.10B Large-cap | 2.25% | 16.93% | 24.85% | -6.64% | -4.32% | -17.51% | -11.30% | 17.79% |
| Danaher DHR | 151.04B Large-cap | 0.41% | 11.53% | 12.97% | 0.31% | -7.84% | -21.40% | -14.78% | 16.18% |
| Idexx Laboratories IDXX | 50.94B Large-cap | -0.81% | 21.34% | 27.87% | 39.23% | 57.89% | 32.25% | 84.50% | 68.12% |
| Agilent Technologies A | 33.28B Large-cap | 2.04% | 4.68% | 10.90% | -10.09% | -8.84% | -13.67% | -6.35% | 21.74% |
| Iqvia Holdings IQV | 32.73B Large-cap | 0.03% | 2.01% | 38.47% | -1.85% | -2.03% | -23.21% | -12.98% | 18.56% |
Ownership & Short Interest
Insider Ownership
3.22%
Institutional Ownership
95.81%
Shares Short
4M
Short Ratio
2.92
Short % of Shares Outstanding
2.84%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Natera Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Natera would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NTRA's 52-week high and low?
- In the last 52 weeks, Natera reached a high of $183.00 (on January 13, 2025) and a low of $92.14 (on August 5, 2024).
- What is the market cap and P/E ratio for NTRA?
- Curious about Natera's size and valuation? Its market capitalization stands at 20.85B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -125.58.
- Does NTRA pay dividends? If so, what's the yield?
- As for dividends, Natera isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Natera's main competitors or similar companies to consider before investing?
When looking at Natera, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -17.51% -11.30% Danaher
DHR151.04B Healthcare Diagnostics & Research -21.40% -14.78% Idexx Laboratories
IDXX50.94B Healthcare Diagnostics & Research 32.25% 84.50% Agilent Technologies
A33.28B Healthcare Diagnostics & Research -13.67% -6.35% Iqvia Holdings
IQV32.73B Healthcare Diagnostics & Research -23.21% -12.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Natera Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Natera's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -24.32%, the Debt to Equity ratio from the most recent quarter is 14.69, and its Gross Profit Margin stands at 63.12%.
- What is the recent revenue and earnings growth for NTRA?
- Looking at Natera's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 32.20%, and quarterly earnings saw a YoY growth of N/A.
- How much of NTRA stock is held by insiders and institutions?
- Wondering who owns Natera stock? Company insiders (like executives and directors) hold about 3.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.81%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.